Ignite Creation Date:
2024-05-06 @ 3:25 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02289963
Status:
COMPLETED
Last Update Posted:
2017-06-26
First Post:
2014-11-10
Brief Title:
Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
Sponsor:
Organization:
Sanofi